Firms discuss the ebb and flow of life sciences IP work and explain how they help professionals pivot between specialities
Alban Kang, who has joined Singapore-based Robinson after three decades at Bird & Bird ATMD, shares why he’s eyeing AI and patent cases
The impact of the recently agreed treaty may be modest at first but is likely to become more significant over time
Lawyers say the opening of the Milan central division this month is likely to boost the so far 'modest' activity in Italy
Jeffrey Morton, formerly a life sciences leader at Procopio, said he was drawn to Haynes Boone’s desire to grow in the sector
Siegmund Gutman, former chair of the life sciences patent group at Proskauer, is among a group of 10 lawyers to join Mintz Levin
Foley Hoag, which has hired a former in-house counsel at a biotech company, is the latest firm to expand its life sciences capabilities
Kate Cassidy expects that AI and developing deals will create a demand for strong life sciences litigators
The UPC’s Court of Appeal said Mathys & Squire and Bristows hadn’t proved a 'direct and present interest' in Ocado v Autostore
The latest copy of a draft pandemic treaty shows the US and its allies are digging in over developing countries’ request for mandatory tech transfer
The latest working draft, seen by Managing IP, features competing visions of a pandemic IP regime advanced by the US and developing nations
The EPO declined to attend the latest meeting organised by the Industry Patent Quality Charter, a group that has called on the office to grant higher-quality patents
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement -
Sponsored by Purplevine IPXiaojuan Yu of Purplevine IP Group discusses the medical device industry in China and considers why changes to the law are welcomed
-
Sponsored by FB RiceLee Miles of FB Rice discusses Australia’s patent box scheme which is set to introduce the agricultural and low emissions technology sectors
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners discuss an IP case that led to the discovery, and removal, of fake fire-resistant glass from hospitals in Turkey
-
Sponsored by Wanhuida Intellectual PropertyThe China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The former head of life sciences at Kramer Levin has joined Orrick, a firm that hopes to grow in the sector
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
Each week Managing IP speaks to a different IP practitioner about their life and career
Interviews; Exclusives
Interviews; Exclusives
Senior leaders at Orrick reveal why they expect more client interest in the life sciences sector and discuss the firm’s work on AI cases
Pravin Anand and Vaishali Mittal of Anand & Anand explain how they helped Swiss pharma company Vifor secure a landmark win against generic companies in India
Mike Renaud, head of the IP division at Mintz, explains his business strategy and how the firm justifies charging higher rates
Fatima Hassan, director of Health Justice Initiative, says IP office actions can yield major wins for patients and activists
Each week Managing IP speaks to a different IP lawyer about their life and career
Counsel explain how they helped Eli Lilly overturn a damages award related to its migraine drug and why Supreme Court guidance proved useful
-
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone
In the latest episode, Managing IP is joined by WIPO director general Daren Tang to discuss traditional knowledge, artificial intelligence, and bringing IP to the ‘man on the street’
In the latest episode, Managing IP is joined by Gwilym Roberts and Lee Davies from the Chartered Institute of Patent Attorneys to discuss the UPC, IP ministers, diversity and more
In the latest episode, the team discusses the battle to take control of listed company and IP business Qantm IP, and looks at some recent hiring trends
The winner of Managing IP’s Life Achievement Award discusses 50 years in IP law and how even he can’t avoid imposter syndrome
In the latest episode of our monthly podcast, the team discusses AI clarifications from India and the US, and previews the upcoming Managing IP Awards for EMEA and the Americas
Managing IP’s Max Walters appeared on the latest episode of ‘Two IPs in a pod’, a regular podcast hosted by the UK patent attorney body, to discuss AI, awards and more
In the latest episode of our monthly podcast, the team discusses standard-essential patent developments so far this year and delves into law firm hiring strategies
In the final episode of 2023, the team discusses our Top 50 and the biggest IP events of the year
In the latest episode of our monthly podcast, the team discusses six months of India’s reformed system for foreign law firms, the latest UPC trends and SEP developments
In this special podcast, Managing IP talks to a charity that is working tirelessly to support mental health initiatives in the IP profession
